IP Library Granted Patent US 7,807,107
Granted Patent B2
US 7,807,107 · App. 12/026,142 · Granted Oct 5, 2010

Particle agglutination-evaluating container

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,807,107
App. No.
12/026,142
Granted
Oct 5, 2010
Kind
B2
Abstract

A particle agglutination-evaluating container for immunological analysis, based on an agglutinate formed in an agglutination reaction between an antibody- or antigen-containing sample and agglutination particles, includes a transparent container body having a bottom face including a sloping bottom face and a raised bottom face extended in a horizontal direction at the top of the sloping bottom face to form an obtuse angle with the sloping bottom face, and a fluidal separation layer containing insoluble particles which are filled in the container body and where the agglutination particles are separated according to the agglutination degree, wherein agglutination is evaluated by observation from the bottom of the container body, where the agglutination reaction is judged positive when the agglutination particles are observed through the raised bottom face, negative when observed at the bottom end of the sloping bottom face, and weakly positive when observed in the middle of the sloping bottom face.

Claims (27)

1. A particle agglutination-evaluating container for use in immunological analysis, based on an agglutinate formed in an agglutination reaction between an antibody- or antigen-containing sample and agglutination particles, comprising:

a transparent container main body having a raised bottom including a sloping bottom face and a raised bottom face extended in a horizontal direction at the top of the sloping bottom face to form an obtuse angle with the sloping bottom face; and

a funnel-shaped sample inlet attached on an internal wall of transparent container main body; and

a fluidal separation layer containing insoluble particles which are filled in the transparent container main body and where the agglutination particles are separated according to the degree of agglutination,

wherein the agglutination particles form an agglutinate and are located on a top face of the fluidal separation layer when the agglutination reaction is positive, the agglutination particles do not form an agglutinate and migrate to the bottom of the sloping bottom face when the agglutination reaction is negative, and the agglutination particles form an agglutinate and are located in an intermediate region of the fluidal separation layer when the agglutination reaction is weakly positive between positive and negative, and thus agglutination is evaluated by observation from the bottom face side of the transparent container main body, where the agglutination reaction is judged positive when the agglutination particles are observed through the raised bottom face, negative when the agglutination particles are observed at the bottom end of the sloping bottom face, and weakly positive when the agglutination particles are observed in the middle of the sloping bottom face.

2. A particle agglutination-evaluating container for use in immunological analysis, based on an agglutinate formed in an agglutination reaction between an antibody- or antigen-containing sample and agglutination particles, comprising:

a transparent container main body having a raised bottom raised in a shape of a truncated cone or pyramid, where the raised bottom face includes a sloping bottom face and the vertex region of the bottom face forms a raised bottom face extended in a horizontal direction in the vertex region of the raised bottom; and

a funnel-shaped sample inlet attached on an internal wall of transparent container main body; and

a fluidal separation layer containing insoluble particles which are filled in the transparent container main body and where the agglutination particles are separated according to the degree of agglutination,

wherein the agglutination particles form an agglutinate and are located on a top face of the fluidal separation layer when the agglutination reaction is positive, the agglutination particles do not form an agglutinate and migrate to the bottom of the sloping bottom face when the agglutination reaction is negative, and the agglutination particles form an agglutinate and are located in an intermediate region of the fluidal separation layer when the agglutination reaction is weakly positive between positive and negative, and thus agglutination is evaluated by observation from the bottom face side of the transparent container main body, where the agglutination reaction is judged positive when the agglutination particles are observed through the raised bottom face, negative when the agglutination particles are observed at the bottom end of the sloping bottom face, and weakly positive when the agglutination particles are observed in the middle of the sloping bottom face.

3. The particle agglutination-evaluating container according to claim 2 , wherein the bottom face of the transparent container main body includes a sloping bottom face raised in a shape of a truncated circular cone, where the vertex region of the bottom face forms a raised bottom face extended in a horizontal direction.

4. The particle agglutination-evaluating container according to claim 1 , wherein the raised bottom face is a flat surface.

5. The particle agglutination-evaluating container according to claim 1 , wherein a thickness of the fluidal separation layer deposited on the raised bottom face of the transparent container main body is 2 mm or less.

6. The particle agglutination-evaluating container according to claim 1 , wherein the gradient angle of the sloping bottom face of the transparent container main body is 45° to 75° with respect to the horizontal plane.

7. The particle agglutination-evaluating container according to claim 1 , wherein the gradient angle of the sloping bottom face of the transparent container main body increases in a region closer to the bottom of the sloping bottom face.

8. The particle agglutination-evaluating container according to claim 1 , wherein a width of the raised bottom face is ½ or less of a width of the transparent container main body, when the transparent container main body is observed from a side wall direction.

9. The particle agglutination-evaluating container according to claim 1 , wherein the sample inlet injects an antibody- or antigen-containing sample collectively onto the fluidal separation layer deposited on the raised bottom face.

10. The particle agglutination-evaluating container according to claim 1 , wherein the sloping bottom face of the transparent container main body is surface-roughened.

11. The particle agglutination-evaluating container according to claim 1 , wherein the insoluble particles are glass bead or crosslinked polymer particles and the particle diameter is 25 to 200 μm.

12. The particle agglutination-evaluating container according to claim 1 , wherein the fluidal separation layer contains an antiserum.

13. A particle agglutination-evaluating container for use in immunological analysis of a plurality of samples, based on an agglutinate formed in each agglutination reaction between a plurality of antibody- or antigen-containing samples and a plurality of kinds of agglutination particles corresponding to the respective samples, wherein the container has a plurality of wells, and each well comprises transparent well main body having a raised bottom including a sloping bottom face and a raised bottom face extended in a horizontal direction at the top of the sloping bottom face to form an obtuse angle with the sloping bottom face, a funnel-shaped sample inlet attached on an internal wall of transparent container main body; and a fluidal separation layer containing insoluble particles which are filled in the each well and where the agglutination particles are separated according to the degree of agglutination.

14. A particle agglutination-evaluating container for use in immunological analysis, based on an agglutinate formed in an agglutination reaction between an antibody- or antigen-containing sample and agglutination particles, comprising:

a container main body having a transparent raised bottom which is raised in a mountain-like shape;

a funnel-shaped sample inlet attached on an internal wall of transparent container main body; and a fluidal separation layer containing insoluble particles which are filled in the transparent container main body and where the agglutination particles are separated according to the degree of agglutination.

15. A particle agglutination-evaluating container for use in immunological analysis of a plurality of samples, based on an agglutinate formed in each agglutination reaction between a plurality of antibody- or antigen-containing samples and a plurality of kinds of agglutination particles corresponding to the respective samples,

wherein the container has a plurality of wells, and

each well comprises a well main body having a transparent raised bottom which is raised in a mountain-like shape, a funnel-shaped sample inlet attached on an internal wall of transparent container main body; and a fluidal separation layer containing insoluble particles which are filled in the each well and where the agglutination particles are separated according to the degree of agglutination.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2010
From: OLYMPUS CORPORATION
To: BECKMAN COULTER, INC.
Reel/Frame 023778/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2008
From: TAMAI, TOYOHIRO; NARITA, HITOSHI; KANEKO, YASUNOBU; KOBAYASHI, YUMI
To: OLYMPUS CORPORATION
Reel/Frame 020877/0719 →